-
1
-
-
79955068635
-
Finasteride for chronic central serous chorioretinopathy
-
Forooghian F, Meleth AD, Cukras C, et al. Finasteride for chronic central serous chorioretinopathy. Retina 2011;31:766-71.
-
(2011)
Retina
, vol.31
, pp. 766-771
-
-
Forooghian, F.1
Meleth, A.D.2
Cukras, C.3
-
2
-
-
78650240629
-
Central serous chorioretinopathy: An update on pathogenesis and treatment
-
Gemenetzi M, De Salvo G, Lotery AJ. Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (Lond) 2010;24:1743-56.
-
(2010)
Eye (Lond)
, vol.24
, pp. 1743-1756
-
-
Gemenetzi, M.1
De Salvo, G.2
Lotery, A.J.3
-
4
-
-
0036757346
-
Central serous chorioretinopathy and glucocorticoids
-
DOI 10.1016/S0039-6257(02)00338-7, PII S0039625702003387
-
Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002;47:431-48. (Pubitemid 35341618)
-
(2002)
Survey of Ophthalmology
, vol.47
, Issue.5
, pp. 431-448
-
-
Bouzas, E.A.1
Karadimas, P.2
Pournaras, C.J.3
-
6
-
-
0020510795
-
Diffuse retinal epitheliopathy and central serous chorioretinopathy
-
in French
-
Cohen D, Gaudric A, Coscas G, et al. [Diffuse retinal epitheliopathy and central serous chorioretinopathy] (in French). J Fr Ophtalmol 1983;6:339-49.
-
(1983)
J Fr Ophtalmol
, vol.6
, pp. 339-349
-
-
Cohen, D.1
Gaudric, A.2
Coscas, G.3
-
7
-
-
0036789478
-
Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: A rationale for new treatment strategies
-
Jampol LM, Weinreb R, Yannuzzi L. Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies. Ophthalmology 2002;109:1765-6.
-
(2002)
Ophthalmology
, vol.109
, pp. 1765-1766
-
-
Jampol, L.M.1
Weinreb, R.2
Yannuzzi, L.3
-
10
-
-
84856072729
-
-
accessed 3 Oct 2011
-
UpToDate. Rifampin. http://www.uptodate.com/contents/rifampin-rifampicin- drug-information?source=search-result&selectedTitle=1%E150 (accessed 3 Oct 2011).
-
Rifampin
-
-
-
11
-
-
0003081722
-
Treatment and Prophylaxis of Bacterial Infections
-
a.P.R. e.a. Fauci AS, ed. Chapter 127: 17th edn. New York: McGraw-Hill
-
Archer G, a.P.R. Harrison's Principles of Internal Medicine. In: e.a. Fauci AS, ed. Chapter 127: Treatment and Prophylaxis of Bacterial Infections. 17th edn. New York: McGraw-Hill, 2008.
-
(2008)
Harrison's Principles of Internal Medicine.
-
-
Archer, G.1
-
12
-
-
0032924934
-
Cytochrome P-450 3A4: Regulation and role in drug metabolism
-
DOI 10.1146/annurev.pharmtox.39.1.1
-
Guengerich FP. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 1999;39:1-17. (Pubitemid 29222549)
-
(1999)
Annual Review of Pharmacology and Toxicology
, vol.39
, pp. 1-17
-
-
Guengerich, F.P.1
-
13
-
-
0026531077
-
Pharmacokinetic drug interactions with rifampicin
-
Venkatesan K. Pharmacokinetic drug interactions with rifampicin. Clin Pharmacokinet 1992;22:47-65.
-
(1992)
Clin Pharmacokinet
, vol.22
, pp. 47-65
-
-
Venkatesan, K.1
-
15
-
-
0026451998
-
Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes
-
Kerlan V, Dreano Y, Bercovici JP, et al. Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes. Biochem Pharmacol 1992;44:1745-56.
-
(1992)
Biochem Pharmacol
, vol.44
, pp. 1745-1756
-
-
Kerlan, V.1
Dreano, Y.2
Bercovici, J.P.3
-
16
-
-
1342281163
-
Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450
-
DOI 10.1124/dmd.32.3.305
-
Miller KK, Cai J, Ripp SL, et al. Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450. Drug Metab Dispos 2004;32:305-13. (Pubitemid 38263888)
-
(2004)
Drug Metabolism and Disposition
, vol.32
, Issue.3
, pp. 305-313
-
-
Miller, K.K.M.1
Cai, J.2
Ripp, S.L.3
Pierce Jr., W.M.4
Rushmore, T.H.5
Prough, R.A.6
-
17
-
-
0029584276
-
Substrates of human hepatic cytochrome P450 3A4
-
DOI 10.1016/0300-483X(95)03155-9
-
Li AP, Kaminski DL, Rasmussen A. Substrates of human hepatic cytochrome P450 3A4. Toxicology 1995;104:1-8. (Pubitemid 26016371)
-
(1995)
Toxicology
, vol.104
, Issue.1-3
, pp. 1-8
-
-
Li, A.P.1
Kaminski, D.L.2
Rasmussen, A.3
-
18
-
-
33645106219
-
Cholesterol-metabolizing cytochromes P450
-
Pikuleva IA. Cholesterol-metabolizing cytochromes P450. Drug Metab Dispos 2006;34:513-20.
-
(2006)
Drug Metab Dispos
, vol.34
, pp. 513-520
-
-
Pikuleva, I.A.1
-
19
-
-
33750027681
-
Cytochrome P450s and cholesterol homeostasis
-
DOI 10.1016/j.pharmthera.2006.05.014, PII S0163725806001161
-
Pikuleva IA. Cytochrome P450s and cholesterol homeostasis. Pharmacol Ther 2006;112:761-73. (Pubitemid 44573496)
-
(2006)
Pharmacology and Therapeutics
, vol.112
, Issue.3
, pp. 761-773
-
-
Pikuleva, I.A.1
-
20
-
-
0031748287
-
Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones
-
DOI 10.1080/004982598239290
-
Niwa T, Yabusaki Y, Honma K, et al. Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica 1998;28:539-47. (Pubitemid 28307940)
-
(1998)
Xenobiotica
, vol.28
, Issue.6
, pp. 539-547
-
-
Niwa, T.1
Yabusaki, Y.2
Honma, K.3
Matsuo, N.4
Tatsuta, K.5
Ishibashi, F.6
Katagiri, M.7
-
21
-
-
84856072504
-
-
accessed 3 Oct 2011
-
Epocrates. Rifampin. https://online.epocrates.com/noFrame/showPage.do? method=analyze&MonographId=280&MultiBrandAlert=false (accessed 3 Oct 2011).
-
Rifampin
-
-
-
22
-
-
84856071050
-
-
PDR.net. (accessed 3 Oct 2011)
-
PDR.net. Rifampin. 2011. http://www.pdr.net/drugpages/concisemonograph. aspx?concise=564 (accessed 3 Oct 2011).
-
(2011)
Rifampin
-
-
-
23
-
-
84856071529
-
-
Drugstore.com. (accessed 3 Oct 2011)
-
Drugstore.com. http://www.drugstore.com/rifampin/rifadin/300mg-capsules/ qxn00527131530 (accessed 3 Oct 2011).
-
-
-
|